Autoantibodies against the Thrombin receptor (PAR-1) are substantially reduced in patients with heart failure: results from the CIBIS-ELD trial.
- R Dechend (Author)
- DN Mueller (Author)
- HD Heidecke (Author)
- A Busjahn (Author)
- DN Dragun (Author)
- Burkert Mathias Pieske (Author)
- G Riemekasten (Author)
- E Tahirovic (Author)
- TD Trippel (Author)
- HD Duengen (Author)
Activity: Talk, presentation or poster › Poster